شانسی فینجیو — دنیا کو چین کے ذائقے سے لطف اندوز کریں

تائی یوان، چین، 4 ستمبر 2023ء/سنہوا-ایشیانیٹ/– شانشی فینجیو کو مسلسل پانچ مرتبہ قومی الکوحل کی تشخیص کے میلے میں قومی شہرت یافتہ شراب قرار دیا گیا ہے۔ چین میں “چار مشہور بائی جیو (چینی شراب کی ایک قسم)” میں سے ایک کے طور پر، فینجیو واحد چینی بائیجیو ہے جو 6،000 سالوں سے مسلسل گزر رہا ہے، جو عالمی شراب ثقافت کی تاریخ میں ایک عظیم معجزہ ہے.

6,000 سال قبل، فینجیو صوبہ شانسی کے ژنگ ہواکون میں پیدا ہوا تھا ، جس کے آباؤ اجداد نے “چھوٹے منہ اور تیز نچلے کلش” کے ساتھ ابتدائی اناج الکوحل تیار کیا تھا۔ فینجیو کی شراب سازی کی ٹیکنالوجی دوسرے چینی بائیجیو کی پیداوار کی بنیاد ہے۔

شانسی فینجیو

فینجیو نہ صرف مشہور چینی بائیجیو کا ایک شاندار نمائندہ ہے ، بلکہ صاف ذائقے والی شراب بنانے والا قومی معیار بھی ہے۔ اپنی طویل شراب سازی کی تاریخ، شاندار شراب سازی کی تکنیک، عمدہ معیار کے ساتھ، فینجیو دنیا میں “سب سے صاف، خالص ترین، صحت مند اور سب سے زیادہ تہذیب یافتہ” مشہور شراب بن گیا ہے.

ماخذ: فین جیو گروپ

تصویری منسلکات لنکس:   https://iop.asianetnews.net/view-attachment?attach-id=442030

 

 

 

Shanxi Fenjiu — Let the world enjoy the taste of China

TAIYUAN, China, Sept. 4, 2023 /Xinhua-AsiaNet/– Shanxi Fenjiu has been rated as a national famous alcohol in the national alcohol evaluation fair for five consecutive times. As one of the “four famous Baijiu (a type of Chinese liquor)” in China, Fenjiu is the only Chinese Baijiu that has been passed down continuously for 6,000 years, which is a great miracle in the history of the world alcohol culture.

Shanxi Fenjiu

As early as 6,000 years ago, Fenjiu was born in Xinghuacun of Shanxi Province, whose ancestors produced the earliest grain alcohol with “small-mouth and sharp-bottom urn”. The brewing technology of Fenjiu is the basis for producing other Chinese Baijiu.

Fenjiu is not only an outstanding representative of famous Chinese Baijiu, but also a national standard maker of clear-flavor liquor. With its long brewing history, superb brewing techniques, excellent quality, Fenjiu has become the “clearest, purest, healthiest and most cultured” famous alcohol in the world.

Source: FEN JIU GROUP

Image Attachments Links: https://iop.asianetnews.net/view-attachment?attach-id=442030

Gemcorp Capital appoints former UK Middle East Trade Commissioner to lead regional expansion

DUBAI, United Arab Emirates, Sept. 03, 2023 (GLOBE NEWSWIRE) — Gemcorp Capital Management today announces its expansion in the Middle East. The new regional operation will be led by Simon Penney, formally His Majesty’s Trade Commissioner for the Middle East for the UK Government. This strategic move reflects Gemcorp’s continued commitment to building a local presence in the emerging markets and focus on the Middle East region’s ambitious growth plans and investment opportunities.

Simon Penney’s extensive experience and leadership will be instrumental in driving Gemcorp’s origination and fundraising activities in the region and developing partnerships with Gulf investors and institutions to access projects across the emerging markets. Under his tenure as the UK’s trade commissioner, trade with the region hit all-time highs alongside establishing multi-billion dollar investment partnerships with a number of Gulf countries.  Simon has spent most of his career in the banking sector leading financial institutions across Europe, the Middle East, Africa and Asia. These included roles as: Head of Wholesale and International Banking at First Gulf Bank (UAE); CEO, Middle East and Africa at Royal Bank of Scotland; and CEO at ABN AMRO Bank (South Africa).

Gemcorp Capital’s Chief Executive Officer, Atanas Bostandjiev, said: “The region’s strategic location, robust infrastructure and business-friendly environment serve as an ideal gateway to access the exciting opportunities that the Middle East and surrounding regions have to offer. Developing a true partnership with local institutions is one of our key business principles. We look forward to applying our emerging markets expertise to investing in the region and aspire to become an important conduit between the Middle East and Africa and the wider emerging markets. With Simon at the helm of our regional business, we aim to become a regional partner of choice for infrastructure, technology and energy transition opportunities.”

Simon Penney expressed enthusiasm about the new role and the opportunities it presents: “I am excited to be leading Gemcorp Capital’s operations in the Middle East. The region’s crucial geographical and geopolitical position make it an ideal launchpad for Gemcorp Capital’s continued growth.

“Gemcorp Capital has consistently demonstrated expertise in navigating the complexities of emerging markets, fostering capital investment and job creation and generating sustainable returns for its investors.”

About Gemcorp Capital Management

Gemcorp Capital is as an independent investment management firm focused on emerging markets. Gemcorp Capital has facilitated over US$7 billion worth of investments in credit and equity transactions since inception. The firm is looking to invest at least $10 billion in Africa over the next decade, mainly in the form of debt deals in partnership with other institutional investors.

Media Enquiries:

gemcorp@citigatedewerogerson.com 

GlobeNewswire Distribution ID 8915072

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Shift4 Payments, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – FOUR

NEW YORK, Sept. 03, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Shift4 Payments, Inc. (NYSE: FOUR) between November 10, 2021 and April 18, 2023, both dates inclusive (the “Class Period”), of the important October 19, 2023 lead plaintiff deadline.

SO WHAT: If you purchased Shift4 securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Shift4 class action, go to https://rosenlegal.com/submit-form/?case_id=18626 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 19, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Shift4 had inadequate disclosure controls and procedures and internal control over financial reporting; (2) as a result, Shift4 failed to properly account for customer acquisition costs, thereby artificially inflating its net cash provided by operating activities; (3) accordingly, Shift4 would likely be forced to restate one or more of its previously issued financial statements; (4) Shift4 employed accounting maneuvers in connection with, among other things, its mass strategic buyout program and sponsor bank merchant settlement account, that were designed to present an inaccurate picture of, inter alia, the Company’s performance, its underlying business quality, and its earnings power; (5) all the foregoing, once revealed, was likely to negatively impact Shift4’s reputation and business; and (6) as a result, the Company’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Shift4 class action, go to https://rosenlegal.com/submit-form/?case_id=18626 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
[email protected]
[email protected]
www.rosenlegal.com

GlobeNewswire Distribution ID 8915464

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Syneos Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SYNH

WHY: NEW YORK, Sept. 03, 2023 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Syneos Health, Inc. (NASDAQ: SYNH) between September 9, 2020 and November 3, 2022, both dates inclusive (the “Class Period”), of the important September 25, 2023 lead plaintiff deadline.

SO WHAT: If you purchased Syneos securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Syneos class action, go to https://rosenlegal.com/submit-form/?case_id=17965 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 25, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Syneos’ business development capabilities had been materially impaired by workforce reductions and leadership and operational changes, as well as labor force turmoil caused by the COVID-19 pandemic; (2) Syneos had struggled to integrate recent acquisitions, causing Syneos to suffer from a bloated and confused organizational structure and impairing Syneos’ ability to provide comprehensive or effective customer engagement across its product portfolio; (3) Syneos was suffering from acute competitive disadvantages as clinical trials moved to remote monitoring and decentralized administration, as Syneos lacked the tools possessed by some of its rivals to successfully run remote and decentralized trials, such as certain data visualization and statistical modeling capabilities, and Syneos had failed to adapt to changing business demands in the wake of the COVID-19 pandemic; (4) Syneos’ backlog, book-to-bill ratios, and net new business awards had been artificially inflated by more than $500 million through the inclusion of reimbursable expenses that Syneos would never collect; (5) as a result of the above, Syneos was struggling to execute on its existing contracts and to agilely respond to its client needs, causing Syneos to suffer client dissatisfaction across its client base; and (6) consequently, Syneos was exposed to a material undisclosed risk that Syneos would lose customers, be unable to grow its client base or win significant contract renewals, and cede market share to its rivals. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Syneos class action, go to https://rosenlegal.com/submit-form/?case_id=17965 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
[email protected]
[email protected]
www.rosenlegal.com

GlobeNewswire Distribution ID 8915475